Press Releases
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
July 16, 2020•With resurgent COVID-19, enrollment has accelerated in Miami, Houston, and IrvineRADNOR, Pa. and GENEVA, July 16, 2020 (GLOBE NEWSWIRE) -- NeuroRx, Inc., in partnership with RELIEF THERAPEUTICS Holdings AG (SIX:RLF, OTC:RLFTF) today announced that the independent Data...
-
June 24, 2020•Fast Track Designation of RLF-100 for the treatment of Acute Lung Injury/Acute Respiratory Distress Syndrome associated with COVID-19 underscores the urgent need for new treatment options for these patients.
RADNOR, Pa. and GENEVA, June 24, 2020 (GLOBE NEWSWIRE) -- NeuroRx, Inc., in partnership with RELIEF THERAPEUTICS Holding AG (SIX:RLF) “Relief” today announced that the U.S. Food and Drug...
-
June 11, 2020•Clinical trial to enroll 144 patients total with expansion to additional sites
HOUSTON, June 11, 2020 (GLOBE NEWSWIRE) -- RELIEF THERAPEUTICS Holding AG (SIX:RLF) “Relief” and its U.S. partner, NeuroRx, Inc. today announced that Houston Methodist Hospital is...
-
June 8, 2020•Clinical trial expanded to patients treated with both noninvasive and mechanical ventilation in critical COVID-19
GENEVA and RADNOR, Pa., June 08, 2020 (GLOBE NEWSWIRE) -- RELIEF THERAPEUTICS Holding AG (SIX:RLF) “Relief” and its U.S. partner, NeuroRx, Inc. today announced that the Phase 2/3 clinical...
-
June 1, 2020•First participants treated at the University of Miami Miller School of Medicine with intravenous RLF-100
MIAMI, June 01, 2020 (GLOBE NEWSWIRE) -- RELIEF THERAPEUTICS Holding AG (SIX:RLF) (Relief) and its U.S. partner, NeuroRx, Inc. today announced treatment of the first patients with RLF-100 at the...
Click here to view our corporate presentation or on the image below
 |
